| Primary |
| Drug Use For Unknown Indication |
30.2% |
| Anaesthesia |
21.3% |
| Product Used For Unknown Indication |
10.3% |
| Induction Of Anaesthesia |
4.6% |
| Prophylaxis |
4.6% |
| Surgery |
4.0% |
| General Anaesthesia |
3.4% |
| Maintenance Of Anaesthesia |
3.4% |
| Premedication |
3.2% |
| Scoliosis Surgery |
2.9% |
| Analgesic Therapy |
1.7% |
| Hypotonia |
1.7% |
| Pulmonary Hypertension |
1.7% |
| Induction And Maintenance Of Anaesthesia |
1.4% |
| Sensory Disturbance |
1.4% |
| Postoperative Care |
1.1% |
| Vitamin Supplementation |
1.1% |
| Analgesic Effect |
0.6% |
| Antibiotic Prophylaxis |
0.6% |
| Blood Pressure Decreased |
0.6% |
|
| Overdose |
11.4% |
| Hyperthermia Malignant |
9.1% |
| Renal Failure Acute |
6.8% |
| Resuscitation |
6.8% |
| Unwanted Awareness During Anaesthesia |
6.8% |
| Cardio-respiratory Arrest |
4.5% |
| Delayed Recovery From Anaesthesia |
4.5% |
| Delirium |
4.5% |
| Hypertension |
4.5% |
| Priapism |
4.5% |
| Respiratory Arrest |
4.5% |
| Respiratory Distress |
4.5% |
| Tachypnoea |
4.5% |
| Ventricular Fibrillation |
4.5% |
| Vomiting |
4.5% |
| Weight Decreased |
4.5% |
| Acute Respiratory Failure |
2.3% |
| Cardiac Arrest |
2.3% |
| Cardiac Failure Acute |
2.3% |
| Coma |
2.3% |
|
| Secondary |
| Anaesthesia |
28.2% |
| Premedication |
10.3% |
| General Anaesthesia |
7.9% |
| Product Used For Unknown Indication |
7.6% |
| Drug Use For Unknown Indication |
6.8% |
| Induction Of Anaesthesia |
5.8% |
| Prophylaxis |
5.3% |
| Postoperative Care |
4.2% |
| Preoperative Care |
4.2% |
| Pain |
3.9% |
| Scoliosis Surgery |
2.6% |
| Therapeutic Procedure |
2.6% |
| Abdominal Pain |
1.8% |
| Postoperative Analgesia |
1.6% |
| Analgesia |
1.3% |
| Antibiotic Prophylaxis |
1.3% |
| Maintenance Of Anaesthesia |
1.3% |
| Thrombosis Prophylaxis |
1.3% |
| Osteoarthritis |
1.1% |
| Enema Administration |
0.8% |
|
| Renal Failure Acute |
30.6% |
| Anaphylactic Shock |
9.7% |
| Hepatocellular Injury |
8.1% |
| Hypotension |
4.8% |
| Transaminases Increased |
4.8% |
| Weight Decreased |
4.8% |
| Wheezing |
4.8% |
| Jaundice |
3.2% |
| Overdose |
3.2% |
| Rash Maculo-papular |
3.2% |
| Shock |
3.2% |
| Sinus Tachycardia |
3.2% |
| Urticaria |
3.2% |
| Vomiting |
3.2% |
| Acute Generalised Exanthematous Pustulosis |
1.6% |
| Acute Respiratory Failure |
1.6% |
| Cardiac Arrest |
1.6% |
| Drug Administration Error |
1.6% |
| Erythema |
1.6% |
| Generalised Erythema |
1.6% |
|
| Concomitant |
| Drug Use For Unknown Indication |
32.8% |
| General Anaesthesia |
11.5% |
| Product Used For Unknown Indication |
6.8% |
| Anaesthesia |
6.3% |
| Blood Pressure Increased |
4.2% |
| Neoplasm |
3.6% |
| Prophylaxis |
3.6% |
| Atrial Fibrillation |
3.1% |
| Induction Of Anaesthesia |
3.1% |
| Neuromuscular Blockade Reversal |
3.1% |
| Premedication |
3.1% |
| Aortic Dissection |
2.6% |
| Aortic Surgery |
2.6% |
| Antibiotic Prophylaxis |
2.1% |
| Enteritis Infectious |
2.1% |
| Nodular (Follicular) Lymphoma |
2.1% |
| Preoperative Care |
2.1% |
| Tachycardia |
2.1% |
| Analgesic Therapy |
1.6% |
| Infection Prophylaxis |
1.6% |
|
| Cardiac Arrest |
15.6% |
| Sinus Tachycardia |
9.4% |
| Anaphylactic Shock |
6.3% |
| Monoplegia |
6.3% |
| Urticaria |
6.3% |
| Urticaria Generalised |
6.3% |
| Ventricular Hypokinesia |
6.3% |
| Ventricular Tachycardia |
6.3% |
| Atrioventricular Block |
3.1% |
| Cardio-respiratory Arrest |
3.1% |
| Depressed Level Of Consciousness |
3.1% |
| Hepatic Enzyme Increased |
3.1% |
| Liver Disorder |
3.1% |
| Meningitis Aseptic |
3.1% |
| Myocardial Infarction |
3.1% |
| Neuromuscular Block Prolonged |
3.1% |
| Overdose |
3.1% |
| Pancreatitis Necrotising |
3.1% |
| Shock |
3.1% |
| Sinus Disorder |
3.1% |
|
